). Nitric oxide is a free radical gas synthesized enzymatically from the amino acid L-arginine in a number of tissues using the three isoforms of nitric oxide synthase (NOS) [4] .
-independent isoform and synthesizes high M concentrations of nitric oxide over a period of hours. Nitric oxide is important in the endotheliumdependent regulation of blood flow and pressure, inhibiting the activation of blood platelets, neurotransmission and memory (long-term potentiation; LTP). Nitric oxide is also involved with host-defence and the inflammatory cascade (exhaustively reviewed in [4]). Since the half-life of nitric oxide at physiological pH is Ͻ5s, its formation in vivo can be quantitated by the measurement of its stable oxidation products, nitrite (NO2

Ϫ ) and nitrate (NO3
Ϫ
) and from the S-nitrosation of free or protein thiols (S-nitrosothiols)
The roles of nitric oxide and ONOO Ϫ in the cardiovascular system have been exhaustively studied and reviewed in great detail elsewhere [4, 7] . [8] inhibitors alone can increase blood pressure clearly demonstrating a role for nitric oxide in regulating blood pressure homeostasis under physiological conditions. Similarly, nitric oxide donating drugs exert potent hypotensive actions [9, 10] .
Briefly, nitric oxide, through the activation of the Ca 2ϩ /calmodulin-dependent enzymes NOS1 and NOS3 maintains cardiac function and vascular patency through direct endothelialdependent interaction with soluble guanylate cylcase resulting in cGMP accumulation, intracellular protein phosphorylation and vasorelaxation. In conditions such as sepsis, shock or inflammation, a third isoform, NOS2 is induced resulting in high concentrations of nitric oxide being synthesized and potentially lethal hypotension. Administration of NOS2 inhibitors effectively attenuate this hypotension in animal models. In otherwise healthy individuals or animals, the administration of NOS3 or more recently NOS1
In [4] or thiols (perhaps including hydrogen sulfide [11] ) is considered beneficial in maintaining a healthy vasculature. Fig. 1 ). H2S may also be formed in vivo from the enzymatic desulfuration of ␤-mercaptopyruvate derived from cysteine transamination [12] 37ЊC, 6.76) [14] and also in animal models of type I diabetes mellitus [15] and pancreatitis [16] although the precise molecular pathways for the induced expression of CSE and activity remain elusive. Similarly, the human CBS gene is located on chromosome 21 (21q22.3) [17] and encodes several mRNA [18] but the function of these mRNA isoforms in terms of H2S synthesis are not known. However, it has been suggested that the heme component of CBS functions as a cellular redox sensor [19] perhaps increasing H2S generation in response to intracellular oxidant load. Interestingly, CBS is allosterically regulated by S-adenosylmethionine [20] and stimulation of CBS activity increases glutathione (GSH) synthesis by promoting cellular cysteine uptake and accompanying increased ␥-glutamylcysteine synthetase activity [21, 22] suggesting a role for CBS (and perhaps H2S) in addressing intracellular redox imbalances due to increased oxidant load. In agreement, H2S or species derived from it at physiological pH, react with several cytotoxic oxidant species such as hypochlorite [23] , peroxynitrite [10] , hydrogen peroxide, O2 - [24, 25] and nitric oxide [26] [37] have reported levels of in excess of 300 M in plasma from healthy rats whereas others [38, 39] [10] , hypochlorite [23] , superoxide [24, 25] , hydrogen peroxide [24, 25] and nitric oxide [26] [57] although it is known to be expressed in human liver [58] and leucocytes [59] . Nevertheless, the few emerging studies examining H2S levels in human blood have clearly shown perturbed H2S synthesis in coronary heart disease [60] and myocardial infarction, where lower H2S levels have been suggested to reflect disease severity (see Table 1 ).
H 2 S biosynthesis
H2S is rapidly emerging as an important gaseous mediator in the vasculature. In sharp contrast to nitric oxide, and as one would expect from an emerging field of research, its vascular effects, its mechanism of action as well as the processes controlling the regulation of its synthesis are poorly understood. As with nitric oxide, H2S is a highly lipophilic molecule and freely penetrates cells of all types. Whether or not H2S and nitric oxide exert their effects in vivo independently or in tandem is currently not known but a growing body of literature is highly suggestive of H2S involvement in the regulation of nitric oxide mediated signalling events and/or vice versa. The bulk of endogenous H2S synthesis in mammalian tissues appears to be from the pyridoxal-5Ј-phosphate-dependent enzymes cystathionine-␥-lyase (CSE; E.C. 4.4.1.1) and cystathionine-␤-synthase (CBS; E.C. 4.2.1.22) and by analogy with NOS use amino acids as substrates; in this case cystathionine, cysteine and homocysteine (summarized in
although it is currently uncertain how this pathway contributes to the levels of H2S reported in mammalian tissues (see below). In should be noted at this point that in aqueous solution H2S is weakly acidic (pKa at
Although experiments in man and animals have clearly shown that removal of endogenous nitric oxide through inhibition of NOS (i.e. with L-NAME) rapidly increases blood pressure, contrasting effects of CSE inhibition (i.e. with PAG) have been reported. For example, injection of PAG exerted little immediate effect on blood
pressure in normotensive anaesthetized rats [61, 62] but increased blood pressure after endotoxic [14] or haemorrhagic shock [52] [55] . [64, 65] , rabbit corpus cavernosum [66] as well as perfused rat mesenteric [67] and hepatic [68] [25, [69] [70] [71] [72] [65, 70, 71] . Patch clamp studies using isolated rat mesenteric [73] and aortic [74] vascular smooth muscle cells exposed to H2S show increased glibenclamide-inhibitable KATP-dependent current and cellular hyperpolarization [75] . However, H2S-mediated opening of KATP channels does not occur in isolated rat cardiomyocytes [76] suggesting the effects of H2S on KATP may be cell specific. [30, 32] 
Plasma or serum levels of H2S in rat, mouse and human adult plasma vary between ~23 and 60 M (summarized in Table 1). Within these reported plasma concentration ranges, H2S induces the relaxation and transient blood pressure reduction in a variety of vascular tissue such as rat aorta and portal vein
vascular beds. H2S has been shown to be produced in myocardial tissue by CSE in vitro and in vivo to protect against hypoxia-reperfusion injury, where it exerts a negative inotropic effect and preserves left ventricular function by lowering left ventricular systolic and end diastolic pressure and reducing infarct size
. The mechanism for the vasculoprotective effects H2S (summarized in Table 2) may be mediated by a direct stimulation of plasma membrane KATP channel-dependent vasorelaxation resulting in increased vascular flow. Rodent aortic ring preparations exposed to high concentrations of K ϩ ions show markedly reduced vasorelaxant response to H2S and KATP channel antagonists such as glibenclamide or 5-hydroxydecanoate (5HD) effectively blocked H2S-mediated vasodilatation
Additional pathways for H2S-mediated vasodilation have also been proposed. For example, H2S activates adenylate cylcase and elevates cAMP in cultured neurons
and isolated human vascular smooth muscle (HVSM) cells [77], suggesting a vasodilatory effect mediated through cAMP is also possible. On the other hand, the activation of this cAMP pathway was not observed in isolated rat cardiomyocytes where the inhibition of L-type Ca
2ϩ channels was proposed [76] or rat vascular endothelial cells [78] .
These findings further suggest cell and perhaps species specific effects of H2S on vascular cells as have been observed with nitric oxide. H2S is further reported to stimulate charybdotoxin/apamin-sensitive K
ϩ channels in vascular endothelium [73, 75] although other laboratories have not observed this [79] . Nevertheless, it is highly likely that, as with nitric oxide the vascular endothelium represents the major target for H2S [55, 73, 75, 79] . Consistent with this, reduced CSE expression/activity and decreased H2S concentration contributes to the pathophysiology of pulmonary hypertension in rodents [80] whereas CBS deficiency leads to hyperhomocyst(e)inemia, increased blood pressure and endothelial dysfunction [81, 82] . Although CBS is not considered to be the vascular source of H2S [55] , tissue deficiencies in CBS are thought to manifest in the vasculature as a consequence of homocysteine accumulation (reviewed in [83, 84] ). Homocysteine is directly toxic to vascular endothelial cells (reviewed in [85, 86] ) and induces apoptotic cell death [87] , [55, 82] [95] and one study has shown that plasma H2S concentrations are decreased with age in adults over 50-80 years old [33] . Together with the observation that H2S-mediated vasodilation is at least partly endothelium dependent [65, [73] [74] [75] 79] 
up-regulates surface expression of intracellular adhesion molecule (ICAM)-1 [88], augments monocyte adhesion [89] and promotes interleukin (IL)-1␤ and tumour necrosis factor-␣ formation [90] and interferes with vascular nitric oxide synthesis and bioavailability [91-94]. Interestingly, homocysteine treatment of Sprague-Dawley rats markedly increased plasma H2S levels via increased expression and activity of CSE [34] and it is tempting to speculate that this response by vascular cells to synthesize vasodilatory H2S in the presence of a detrimental vascular toxin was a protective and/or compensatory response to maintain vascular patency. In rodents, CBS or CSE deficiency induced by genetic deletion or chronic treatment with PAG results in a severe hypertension and severe loss of endothelial function
; this suggests that there is a possible loss of H2S synthesizing capacity or bio-availability over time that parallels age-associated increases in blood pressure in man.
It is possible that part of the vasculoprotective effects may be due to inhibition of platelet aggregation [96] [11, [23] [24] [25] [26] [21, 22, 30, 114] 
. However, this is unlikely since significant inhibition platelet aggregation by H2S (~30 M) at physiologically relevant concentrations was only observed with ADP and millimolar concentrations of NaHS were required to inhibit platelet aggregation induced by other mediators such as collagen, arachidonate and thrombin. It is further likely that H2S removes toxic oxidants that are known to be detrimental to endothelial function in the vasculature
NaHS induces glutathione (GSH) synthesis and decreases plasma levels of oxidized glutathione (GSSG).
Effects observed in neuronal cells. Increased cysteine uptake and increased activity of ␥-glutamylcysteine synthetase; GSH is an effective extracellular and intracellular antioxidant NaHS increased plasma total antioxidant capacity
Effects on vascular cells Inhibition of vascular smooth muscle cell proliferation Activation ERK and p21
cip/WAF -mediated pathway; observed in rat and human cells either treated with NaHS or through over-expression of CSE. [100, 102] However, inhibition of ERK has also been reported. [101] Induction [95]
NaHS inhibited adhesion molecule expression (ICAM-1) in rat model of myocardial ischemia reperfusion
Cardiovascular protective effects of H2S
Protection against myocardial ischemiareperfusion and myocardial infarction injury Preserves left ventricular contractility and reduces infarct size
Opening of mitochondrial KATP channels and up-regulation of BCl2 protein to prevent mitochondrial permeability and release of prodeath factors (i.e. cytochrome c) i.e. H2S is cytoprotective. Inhibition of c-Fos signalling. Inhibition of pro-inflammatory signalling (p38, JNK and NF-B)
[ 69-72, 99, 115] [97] . [78, 98, 99] and preserves mitochondrial ultrastructure and respiratory chain function in vivo [72] possibly via a mitochondrial pathway involving the preservation of Bcl-2 signalling and intriguingly, a mitochondrial KATP-channel-dependent mechanism [99] . H2S is also reported to induce vascular angiogenesis and induced neovascularization in mice in vivo as well as promote proliferation, adhesion and migration in cultured endothelial cells via AKT and phosphatidylinositol 3-kinase phosphorylation [78, 98] . Furthermore, H2S was recently shown to inhibit neointima formation after balloon injury in rat carotid artery in vivo by inhibiting vascular smooth muscle cell proliferation [100, 101] , an effect also observed with HVSM cell proliferation in vitro by either inducing or inhibiting [101] ERK and p21 cip/WAF phosphorylation [102] . Furthermore a pro-apoptotic effect of H2S on HVSM cells has also been proposed, also mediated through ERK/p21
Alternatively, the cytoprotecitve effects of H2S may be due to the initiation of 'protective cellular' signalling pathways within cardiac and vascular tissues. For example, H2S induces extracellular regulated kinase (ERK) and protein kinase B (AKT) signalling pathways in cardiac tissue
cip/wak-1 [103] and p38 pathways involving caspase-3 activation [103, 104] suggesting that the role of H2S in the vasculature is to activate the endothelium and inhibit vascular smooth muscle cell function. Indeed, as with nitric oxide mediated vasorelaxation, the vasodilatatory effects of H2S are endothelium dependent [65, [73] [74] [75] 79 ].
An additional effect of H2S may be due to the inhibition of angiotensin-converting enzyme on the surface of vascular endothelial cells [105] [65] and human arteries [57] . In nonmammalian vertebrates, H2S induces vasorelaxation or vasoconstriction (or both) [13, 106] . In isolated bovine pulmonary arteries H2S causes tissue contraction whereas it induces a complex contraction-relaxation-contraction response in rat pulmonary arteries [106] . Indeed closer examination of the pioneering publications which examined the vasodilator effects of H2S on isolated rat aortic rings clearly show that low concentrations of H2S induce contraction [74, 75, 80] . Although this was not stated in the text of these publications, these findings are clearly visible in the published figures. We recently expanded these early studies and showed that in phenylephrine precontracted rat aortic ring preparations [65] and isolated human internal mammary artery [57] , low concentrations of H2S-induced tissue contraction followed by relaxation. Both of these effects were dependent on intact endothelial cells since denuded tissue showed neither tissue contraction (at low H2S concentrations) or relaxation (at higher H2S concentrations) [65] . Furthermore we also showed that low concentrations of H2S-induced endothelium-dependent vasoconstriction in vitro and in anaesthetized rats this was inhibited by removal of endogenous nitric oxide with L-NAME [65] Kubo et al. [107, 108] showed recombinant NOS1 (rat), NOS2 (mouse) and to a latter extent, NOS3 (bovine) were inhibited by NaHS perhaps through interfering with tetrahydrobiopterin binding. Work by others [63, [109] [110] [111] subsequently showed that H2S inhibited NOS3 but not NOS2 activity in isolated rat and mouse aortic rings [107] and in human umbilical vein endothelial (HUVE) cells [109] [63, 112] The vasorelaxant effect of the nitric oxide donors SNP and SIN-1 were enhanced by incubating rat aortic tissue with NaHS [64] L-NAME inhibited H2S-mediated vasorelaxation in rat aorta and the conversion of L-cysteine to H2S in rat aortic tissue. This effect was enhanced by treatment with the nitric oxide donor SNP [73] NaHS [64, 65] or slow release H2S donor GYY4137 [79] prevented and reversed L-NAME-mediated hypertension in rats [107, 108] H2S, NaHS inhibited L-arginine uptake in human umbilical vein endothelial (HUVE) cells [109, 110] L-cysteine / pyridoxdal phosphate inhibited L-arginine uptake in HUVE cells; inhibited by PAG [109, 110] L-Arginine increased CSE mRNA expression in pulmonary vascular endothelial and smooth muscle cells [110] Nitric oxide donors up-regulated the expression and activity of CSE in vascular tissues and cultured aortic smooth muscle cells [74, 124] Synergistic effect of nitric oxide and H2S on stonustoxin-induced relaxation of isolated rat aorta [123] Synergistic effect of nitric oxide and H2S on rat pulmonary artery relaxation [64] H2S-mediated ischemic after conditioning involved activation of NOS3 [121] Inhibitory effects of H2S on nitric oxide synthesis and nitric oxide mediated vasorelaxation NaHS inhibited recombinant NOS1 (nNOS) and NOS3 (eNOS) activity through interaction with BH4 and NOS2 through unknown mechanisms [107] [108] [109] L-NAME inhibited CSE expression and H2S synthesis in thoracic artery and superior mesenteric artery in rats [80] [65] L-NAME inhibited H2S-induced increase in mean arterial blood pressure in anaesthetized rats [65] H2S inhibited vasorelaxation of isolated human internal mammary artery; induced by nitric oxide dependent mechanisms (i.e. acetylcholine) [57] PAG inhibited SNP-mediated vasorelaxation of isolated rat aorta [114] Other evidence of RNS-H2S interaction [11] Inhibition of tyrosine nitration in vivo in animal model of myocardial ischemia reperfusion [99] Several nitric oxide donors react with NaHS in vitro to form a species resembling an inert 'nitrosothiol' [11, 26, 57, 65] H2S-dependent nitrosothiol formation during lipopolysaccharide-induced septic shock in the rat [26] NaHS-mediated decrease of O2 Ϫ formation in human vascular smooth muscle cells was inhibited by the nitric oxide donor spermine NONOate [77] [63] or to attenuate [65, 75] 
H2S potentiated expression of NOS2 following stimulation of cultured rat vascular muscle cells with interleukin (IL)-1␤ H2S inhibited nitric oxide generation in isolated aortic tissues and in vivo [109] H2S down-regulated NOS3 (eNOS) but not NOS2 (iNOS) expression however, NOS2 was not induced
Nitric oxide dependent relaxation of rat aortic rings through either nitric oxide donors (SNP, SNAP or SIN-1) or nitric oxide dependent (acetylcholine, histamine) but not nitric oxide independent (i.e. isoprenaline) mediators was inhibited by exogenous (H2S gas, NaHS) and endogenous (L-cysteine/pyridoxal phosphate) H2S; an effect reversed by PAG
Concluding remarks
The 
